title: Severe macrophage activation syndrome and central nervous system involvement in juvenile dermatomyositis.
authors.affiliation: Departments of Rheumatology, Oslo University Hospital , Oslo , Norway.
authors.forename: V
authors.initials: V
authors.lastname: Lilleby
authors.forename: J
authors.initials: J
authors.lastname: Haydon
authors.forename: H
authors.initials: H
authors.lastname: Sanner
authors.forename: B K
authors.initials: BK
authors.lastname: Krossness
authors.forename: G
authors.initials: G
authors.lastname: Ringstad
authors.forename: B
authors.initials: B
authors.lastname: Flatø
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use; D002493:Central Nervous System Diseases / Q000175:diagnosis / Q000209:etiology*; D002648:Child; D003882:Dermatomyositis / Q000150:complications* / Q000188:drug therapy; D004487:Edema / Q000175:diagnosis / Q000209:etiology; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000627:therapeutic use; D007375:Interleukin-1 / Q000037:antagonists & inhibitors; D055501:Macrophage Activation Syndrome / Q000175:diagnosis / Q000209:etiology*; D008297:Male; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D053590:Interleukin 1 Receptor Antagonist Protein; D007375:Interleukin-1